What is Caliber Imaging & Diagnostics Inc?
, a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States.
LCDX · Verdict
Moderate reward · elevated risk
LCDX stands out on volatility and valuation, but watch the balance sheet signal.
Based on 88% data coverage
LCDX · Verdict
Top decile vs peers
Above average
Current ratio 0.31
-164% net margin · 0% ROE
-146% free-cash-flow margin
Model-based scoring. For information only — not financial advice.
, a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 5.10K.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.